Ryan Watts is the founder of Denali Therapeutics. Denali Therapeutics has raised $349M in total funding. Latest round: Series A.
Ryan Watts is the co-founder and CEO of Denali Therapeutics, a South San Francisco-based biotech company focused on neurodegenerative diseases. He founded Denali in 2015 after leading neuroscience research at Genentech, joining former Genentech colleagues Alex Shu and Mark Tessier-Lavine.
Full founder directory · Investor directory · Company funding database · Fundraising library